Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme

被引:71
作者
Elflein, H. M. [1 ]
Hofherr, T. [1 ]
Berisha-Ramadani, F. [1 ]
Weyer, V. [2 ]
Lampe, C. [3 ]
Beck, M. [3 ]
Pitz, S. [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Childrens Hosp, Ctr Lysosomal Storage Dis,Villa Metabol, Mainz, Germany
关键词
ENZYME REPLACEMENT THERAPY; OCULAR MANIFESTATIONS; CROSS-LINKING; SCHEIMPFLUG; SAFETY; HAZE; VI;
D O I
10.1136/bjophthalmol-2012-302913
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim To identify a means to objectively measure corneal clouding in patients with mucopolysaccharidosis in a prospective controlled clinical trial. Methods Corneal haze was assessed by slit lamp examination and measured using the densitometry programme of the Pentacam, a rotating Scheimpflug camera in 33 mucopolysaccharidoses (MPS) patients and 32 controls. Results Pentacam measurements were available in 31 right and 31 left eyes of 32 patients and in 32 left and right eyes of 32 subjects in the control group. Slit lamp findings correlated very well with corneal density measurements (Spearman correlation right eye (OD)/left eye (OS)=0.782/0.791). MPS patients had higher density units (median OD/OS=14.1/14.7) than control subjects (median OD/OS=6.7/6.9, p<0.001). In patients, the corneal centre density values (median OD/OS=13.8/14.0) did not differ from corneal periphery values (median OD/OS=14.3/14.7). Conclusions The densitometry programme of the Pentacam provides objective measurement of corneal haze in mucopolysaccharidosis patients.
引用
收藏
页码:829 / 833
页数:5
相关论文
共 25 条
[1]   Mucopolysaccharidoses and the eye [J].
Ashworth, JL ;
Biswas, S ;
Wraith, E ;
Lloyd, IC .
SURVEY OF OPHTHALMOLOGY, 2006, 51 (01) :1-17
[2]   Use of iris recognition camera technology for the quantification of corneal opacification in mucopolysaccharidoses [J].
Aslam, Tariq Mehmood ;
Shakir, Savana ;
Wong, James ;
Au, Leon ;
Ashworth, Jane .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (12) :1466-1468
[3]  
BALESTRAZZI E, 1995, J REFRACT SURG, V11, P181
[4]  
Cho Yang Kyeung, 2010, Korean J Ophthalmol, V24, P284, DOI 10.3341/kjo.2010.24.5.284
[5]   Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I [J].
Clarke, Lorne A. ;
Wraith, J. Edmond ;
Beck, Michael ;
Kolodny, Edwin H. ;
Pastores, Gregory M. ;
Muenzer, Joseph ;
Rapoport, David M. ;
Berger, Kenneth I. ;
Sidman, Marisa ;
Kakkis, Emil D. ;
Cox, Gerald F. .
PEDIATRICS, 2009, 123 (01) :229-240
[6]   Ocular manifestations in patients affected by Morquio syndrome (MPS IV) [J].
Couprie, J. ;
Denis, P. ;
Guffon, N. ;
Reynes, N. ;
Masset, H. ;
Beby, F. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2010, 33 (09) :617-622
[7]  
DREWS R. C., 1964, OPHTHALMOLOGICA, V148, P143
[8]   Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis [J].
Fahnehjelm, Kristina T. ;
Ashworth, Jane L. ;
Pitz, Susanne ;
Olsson, Monica ;
Tornquist, Alba Lucia ;
Lindahl, Paivi ;
Summers, C. Gail .
ACTA OPHTHALMOLOGICA, 2012, 90 (07) :595-602
[9]   OCULAR MANIFESTATIONS OF MUCOPOLYSACCHARIDOSES [J].
FRANCOIS, J .
OPHTHALMOLOGICA, 1974, 169 (05) :345-361
[10]   Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis [J].
Greenstein, Steven A. ;
Fry, Kristen L. ;
Bhatt, Jalpa ;
Hersh, Peter S. .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2010, 36 (12) :2105-2114